Literature DB >> 31136681

Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.

Andrew H Evans1, David Okai2, Daniel Weintraub3,4, Shen-Yang Lim5, Sean S O'Sullivan5,6, Valerie Voon7, Paul Krack8, Cristina Sampaio9, Bart Post10, Albert F G Leentjens11, Pablo Martinez-Martin12, Glenn T Stebbins13, Christopher G Goetz13, Anette Schrag14.   

Abstract

Impulse control disorders (ICDs) and related impulsive and compulsive behaviors (together called ICBs) have been increasingly recognized in the context of Parkinson's disease (PD) and treatment. The International Parkinson's and Movement Disorder Society commissioned a task force to assess available clinical screening instruments and rating scales, including their clinimetric properties, make recommendations regarding their utility, and suggest future directions in scale development and validation. The literature was systematically searched for scales measuring a range of reported ICBs in PD. A scale was designated "recommended" if the scale had been employed in PD studies, been used beyond the group that developed it, and had adequate clinimetric data published for PD. Numerous diagnostic screening tools and severity rating scales were identified for a range of ICBs, including compulsive medication use, punding/hobbyism, walkabout, pathological gambling, hypersexuality, compulsive or binge eating, compulsive buying, reckless driving, compulsive exercise, pyromania, trichotillomania, hoarding, kleptomania, intermittent explosive disorder, and internet addiction. For screening across the range of ICBs (except compulsive medication use), the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease (QUIP) and QUIP-Rating Scale (QUIP-RS) are recommended, and for severity rating across the range of ICBs the QUIP-RS and the Ardouin Scale of Behavior in Parkinson's Disease are recommended. The Scale for Outcomes in Parkinson's Disease-Psychiatric Complications is recommended for rating of hypersexuality and the compulsive behaviors gambling/shopping. Further testing of established scales against gold standard diagnostic criteria is urgently required for all other individual ICBs in PD.
© 2019 International Parkinson and Movement Disorder Society © 2019 International Parkinson and Movement Disorder Society. © 2019 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; clinimetrics; impulse control disorders; rating scales; reliability; validity

Mesh:

Year:  2019        PMID: 31136681     DOI: 10.1002/mds.27689

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort.

Authors:  Sylvia Binck; Claire Pauly; Michel Vaillant; Geraldine Hipp; Manon Gantenbein; Rejko Krueger; Nico J Diederich
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

2.  Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours: results from the COPPADIS cohort.

Authors:  S Jesús; M A Labrador-Espinosa; A D Adarmes; C Méndel-Del Barrio; J C Martínez-Castrillo; A Alonso-Cánovas; P Sánchez Alonso; S Novo-Ponte; M G Alonso-Losada; N López Ariztegui; J C Segundo Rodríguez; M I Morales; I Gastón; F Lacruz Bescos; P Clavero Ibarra; J Kulisevsky; J Pagonabarraga; B Pascual-Sedano; P Martínez-Martín; D Santos-García; P Mir
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

3.  Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).

Authors:  Maiko Takahashi; Jinsoo Koh; Shoko Yorozu; Yoshinori Kajimoto; Yoshiaki Nakayama; Mayumi Sakata; Masaaki Yasui; Yasuhiro Hiwatani; Daniel Weintraub; Hidefumi Ito
Journal:  Parkinsons Dis       Date:  2022-03-23

4.  Genetic prediction of impulse control disorders in Parkinson's disease.

Authors:  Daniel Weintraub; Marijan Posavi; Pierre Fontanillas; Thomas F Tropea; Eugenia Mamikonyan; Eunran Suh; John Q Trojanowski; Paul Cannon; Vivianna M Van Deerlin; Alice S Chen-Plotkin
Journal:  Ann Clin Transl Neurol       Date:  2022-06-27       Impact factor: 5.430

5.  Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System.

Authors:  Michele Fusaroli; Emanuel Raschi; Valentina Giunchi; Marco Menchetti; Roberto Rimondini Giorgini; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Int J Neuropsychopharmacol       Date:  2022-09-28       Impact factor: 5.678

Review 6.  Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis.

Authors:  Lanxiao Cao; Tian Xu; Gaohua Zhao; Dayao Lv; Jinyu Lu; Guohua Zhao
Journal:  J Neurol       Date:  2021-08-09       Impact factor: 4.849

7.  Central Pain in Parkinson's Disease: Behavioral and Cognitive Characteristics.

Authors:  N Vila-Chã; S Cavaco; A Mendes; A Gonçalves; I Moreira; J Fernandes; J Damásio; L F Azevedo; J M Castro-Lopes
Journal:  Parkinsons Dis       Date:  2021-06-10

8.  Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.

Authors:  Daniel S Drew; Kinan Muhammed; Fahd Baig; Mark Kelly; Youssuf Saleh; Nagaraja Sarangmat; David Okai; Michele Hu; Sanjay Manohar; Masud Husain
Journal:  Brain       Date:  2020-08-01       Impact factor: 13.501

9.  Validation of the Chinese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease.

Authors:  Tian Xu; Lanxiao Cao; Wenying Long; Guohua Zhao
Journal:  Front Neurol       Date:  2021-12-07       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.